Submitted by Alkermes
Last week, more than 1,000 Alkermes employees came together virtually to listen to our colleagues who volunteered to share their stories of how racism and bias have impacted their lives. We are grateful to them for their openness and willingness to share the challenges they face. As a company that believes in equality and justice, we have a responsibility to combat discrimination and racism in all forms in our communities. While an important and impactful discussion, this was only the first of many to come as we continue to take action to help eliminate discrimination in all its forms. There is much to be done.
Alkermes plc is a fully-integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The company has a portfolio of proprietary commercial products focused on addiction and schizophrenia, and a pipeline of product candidates in development for schizophrenia, bipolar I disorder, neurodegenerative disorders and cancer. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com.
More from Alkermes